by Drug Target Review –
A new experimental stem cell therapy shows promise in repairing brain damage after ischemic strokes – potentially allowing for the development of future treatments that extend the recovery window.
Strokes are a leading worldwide cause of death and disability. Almost nine out of 10 cases are ischemic strokes, caused by restricted blood flow in the brain. The current, and best, treatment that breaks up blood clots in the brain must be delivered within four and a half hours of symptoms appearing to have the best chance of success.
